EPIGRAL Stock Overview
Manufactures and sells chlor-alkali and related derivatives in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 6/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Epigral Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,866.80 |
| 52 Week High | ₹2,406.75 |
| 52 Week Low | ₹931.60 |
| Beta | -0.10 |
| 1 Month Change | -10.35% |
| 3 Month Change | -18.87% |
| 1 Year Change | 90.16% |
| 3 Year Change | 140.15% |
| 5 Year Change | n/a |
| Change since IPO | 359.29% |
Recent News & Updates
Recent updates
Here's Why Epigral (NSE:EPIGRAL) Has Caught The Eye Of Investors
Dec 18
Epigral Limited's (NSE:EPIGRAL) Shares Leap 29% Yet They're Still Not Telling The Full Story
Jul 04Epigral Limited (NSE:EPIGRAL) Looks Just Right With A 27% Price Jump
Apr 19Epigral Limited (NSE:EPIGRAL) Soars 28% But It's A Story Of Risk Vs Reward
Feb 23Epigral (NSE:EPIGRAL) Might Be Having Difficulty Using Its Capital Effectively
Feb 21Capital Investment Trends At Meghmani Finechem (NSE:MFL) Look Strong
Apr 05With EPS Growth And More, Meghmani Finechem (NSE:MFL) Makes An Interesting Case
Sep 28Meghmani Finechem's (NSE:MFL) Promising Earnings May Rest On Soft Foundations
May 03Meghmani Finechem Limited's (NSE:MFL) Business Is Yet to Catch Up With Its Share Price
Nov 22Shareholder Returns
| EPIGRAL | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -2.5% | -0.6% | 0.2% |
| 1Y | 90.2% | 2.6% | 17.2% |
Return vs Industry: EPIGRAL exceeded the Indian Chemicals industry which returned 2.6% over the past year.
Return vs Market: EPIGRAL exceeded the Indian Market which returned 17.2% over the past year.
Price Volatility
| EPIGRAL volatility | |
|---|---|
| EPIGRAL Average Weekly Movement | 6.9% |
| Chemicals Industry Average Movement | 5.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: EPIGRAL has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: EPIGRAL's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 997 | Kaushal Soparkar | www.epigral.com |
Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda, chlorine, hydrogen, and caustic potash products. It also engages in the trading of agrochemical products.
Epigral Limited Fundamentals Summary
| EPIGRAL fundamental statistics | |
|---|---|
| Market cap | ₹80.54b |
| Earnings (TTM) | ₹2.94b |
| Revenue (TTM) | ₹22.73b |
27.4x
P/E Ratio3.5x
P/S RatioIs EPIGRAL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EPIGRAL income statement (TTM) | |
|---|---|
| Revenue | ₹22.73b |
| Cost of Revenue | ₹13.19b |
| Gross Profit | ₹9.55b |
| Other Expenses | ₹6.61b |
| Earnings | ₹2.94b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 68.04 |
| Gross Margin | 42.00% |
| Net Profit Margin | 12.91% |
| Debt/Equity Ratio | 63.9% |
How did EPIGRAL perform over the long term?
See historical performance and comparisonDividends
0.3%
Current Dividend Yield11%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 19:42 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Epigral Limited is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | BP Wealth Management Private Limited |
| Meet Vora | Emkay Global Financial Services Ltd. |
| Kameswari V. S. Chavali | FirstCall Research |